checkAd

    Biofrontera AG  728  0 Kommentare Notice of report acc. to §§ 37v-x et seqq. WpHG (the German Securities Trading Act) with the aim of pan-European distribution

    Biofrontera AG / Biofrontera AG : Notice of report acc. to §§ 37v-x et seqq. WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

    Biofrontera AG hereby announces that the following financial reports will be disclosed:

    Report: Quarterly report
    Report validity period:
    From: 01.01.2015
    To: 30.09.2015
    Publishing date: 20.11.2015
    Web address: http://biofrontera.com/en/investors/financial-reports/year/2015.html



    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Biofrontera AG via Globenewswire

    HUG#1966438

    Lesen Sie auch

    --- End of Message ---

    Biofrontera AG
    Hemmelrather Weg 201 Leverkusen Germany

    WKN: 604611;ISIN: DE0006046113;
    Listed: Freiverkehr in Börse Stuttgart,
    Freiverkehr in Börse Berlin,
    Freiverkehr in Bayerische Börse München,
    Regulierter Markt in Frankfurter Wertpapierbörse,
    Regulierter Markt in Börse Düsseldorf;




    Diskutieren Sie über die enthaltenen Werte


    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    Biofrontera AG Notice of report acc. to §§ 37v-x et seqq. WpHG (the German Securities Trading Act) with the aim of pan-European distribution Biofrontera AG / Biofrontera AG : Notice of report acc. to §§ 37v-x et seqq. WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely …

    Schreibe Deinen Kommentar

    Disclaimer